B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation

REACTOME PATHWAY
Reactome: R-HSA-98282113 genes11 compounds

The Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation pathway (Reactome ID: R-HSA-9828211) involves 3 genes and is affected by 11 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

IKBKETBK1TLR3

Compounds Affecting Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation

#CompoundTargets HitStudies
1amlexanox96
2Crizotinib298
3Budesonide1,000
4Dibucaine299
5Dimethylphenylpiperazinium Iodide33
6Edaravone298
7Fluocinolone Acetonide295
8Podophyllotoxin14
9Sulfadimethoxine300
10vinblastine sulfate81
11Axitinib298

About the Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation Pathway

The Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation pathway is catalogued in Reactome (ID: R-HSA-9828211) and involves 3 genes. In the BiohacksAI corpus, 11 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include IKBKE, TBK1, TLR3.